Mohawk Industries (MHK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 22, 2025, to elect three Class III directors, ratify KPMG LLP as auditor, and hold an advisory vote on executive compensation.
2024 sales reached $10.8B, with adjusted EBITDA of $1.4B and free cash flow of $680M; net debt to adjusted EBITDA ratio at 1.1x.
Company focused on long-term growth, operational improvements, and sustainability, despite challenging macroeconomic conditions.
Proxy materials are primarily distributed electronically to reduce environmental impact and costs.
Voting matters and shareholder proposals
Shareholders will vote on electing three Class III directors for three-year terms, ratifying KPMG LLP as auditor, and approving executive compensation on an advisory basis.
All proposals require a majority of votes cast for approval.
Shareholders can vote by internet, phone, mail, or in person at the meeting.
Board of directors and corporate governance
Board consists of nine directors in three staggered classes, with a classified board structure to promote stability and long-term focus.
Board members bring diverse expertise in global business, M&A, finance, sustainability, and risk management.
Six directors are independent; a Lead Independent Director role was established to enhance oversight.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, all with independent members.
Annual board and committee self-evaluations are conducted to assess effectiveness.
Stockholder engagement is ongoing, with regular outreach and feedback mechanisms.
Latest events from Mohawk Industries
- Q2 2026 delivered strong sales, margin gains, and EPS growth, aided by tariff refunds and cost actions.MHK
Q2 2026 - Q1 2026 net sales up 8% to $2.73B, adjusted EPS $1.90, net earnings $117M.MHK
Q1 2026 - Annual meeting covers director elections, pay, new incentive plan, and key governance issues.MHK
Proxy filing - Q4 2025 net sales rose 2.4% with strong cash flow; 2026 outlook expects improved earnings.MHK
Q4 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 2025 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 2024 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 2024 - Q1 2025 sales and earnings fell, but cost actions and restructuring support future improvement.MHK
Q1 2025 - Adjusted EPS steady at $1.95 as restructuring offsets weak demand; $285M savings targeted.MHK
Q4 2024